Osaic Holdings
MAZE

Osaic Holdings’s Maze Therapeutics MAZE Stock Holding History

Osaic Holdings’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
77,850
+17,907
+30% +$469K ﹤0.01% 2180
2026
Q1 		$1.79M Buy
59,943
+181
+0.3% +$7.99K ﹤0.01% 2168
2025
Q4 		$2.48M Buy
59,762
+29,237
+96% +$1M ﹤0.01% 1910
2025
Q3 		$792K Buy
30,525
+30,471
+56,428% +$514K ﹤0.01% 3016
2025
Q2 		$595 Buy
+54
New +$562 ﹤0.01% 7319

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Osaic Holdings's MAZE Position: Q2 2026 in Review

Osaic Holdings increased its Maze Therapeutics (MAZE) stake by 30% in Q2 2026, buying an estimated $469K and bringing the position to 77,850 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

Osaic Holdings first reported a position in MAZE in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.48M in Q4 2025. 162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Osaic Holdings held 77,850 shares of Maze Therapeutics worth $2.32M as of Q2 2026.
  • Osaic Holdings bought 17,907 Maze Therapeutics shares in Q2 2026, an estimated $469K.
  • Maze Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2180 holding.
  • Osaic Holdings first reported a position in Maze Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Osaic Holdings's Maze Therapeutics position peaked at $2.48M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.